257 related articles for article (PubMed ID: 29977590)
1. Targeted disruption of the extracellular polymeric network of
Powell LC; Pritchard MF; Ferguson EL; Powell KA; Patel SU; Rye PD; Sakellakou SM; Buurma NJ; Brilliant CD; Copping JM; Menzies GE; Lewis PD; Hill KE; Thomas DW
NPJ Biofilms Microbiomes; 2018; 4():13. PubMed ID: 29977590
[TBL] [Abstract][Full Text] [Related]
2. Alginate Oligosaccharide-Induced Modification of the
Jack AA; Khan S; Powell LC; Pritchard MF; Beck K; Sadh H; Sutton L; Cavaliere A; Florance H; Rye PD; Thomas DW; Hill KE
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29463534
[No Abstract] [Full Text] [Related]
3. Phenotypic and Genotypic Adaptations in Pseudomonas aeruginosa Biofilms following Long-Term Exposure to an Alginate Oligomer Therapy.
Oakley JL; Weiser R; Powell LC; Forton J; Mahenthiralingam E; Rye PD; Hill KE; Thomas DW; Pritchard MF
mSphere; 2021 Jan; 6(1):. PubMed ID: 33472983
[TBL] [Abstract][Full Text] [Related]
4. A Low-Molecular-Weight Alginate Oligosaccharide Disrupts Pseudomonal Microcolony Formation and Enhances Antibiotic Effectiveness.
Pritchard MF; Powell LC; Jack AA; Powell K; Beck K; Florance H; Forton J; Rye PD; Dessen A; Hill KE; Thomas DW
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630204
[TBL] [Abstract][Full Text] [Related]
5. Polyguluronate simulations shed light onto the therapeutic action of OligoG CF-5/20.
Hills OJ; Yong CW; Scott AJ; Smith J; Chappell HF
Bioorg Med Chem; 2022 Oct; 72():116945. PubMed ID: 36037625
[TBL] [Abstract][Full Text] [Related]
6. Cellulose Nanofibril Formulations Incorporating a Low-Molecular-Weight Alginate Oligosaccharide Modify Bacterial Biofilm Development.
Jack AA; Nordli HR; Powell LC; Farnell DJJ; Pukstad B; Rye PD; Thomas DW; Chinga-Carrasco G; Hill KE
Biomacromolecules; 2019 Aug; 20(8):2953-2961. PubMed ID: 31251598
[TBL] [Abstract][Full Text] [Related]
7. OligoG CF-5/20 Disruption of Mucoid Pseudomonas aeruginosa Biofilm in a Murine Lung Infection Model.
Hengzhuang W; Song Z; Ciofu O; Onsøyen E; Rye PD; Høiby N
Antimicrob Agents Chemother; 2016 May; 60(5):2620-6. PubMed ID: 26833153
[TBL] [Abstract][Full Text] [Related]
8. Extracellular DNA enhances biofilm integrity and mechanical properties of mucoid
Ferguson DL; Gloag ES; Parsek MR; Wozniak DJ
J Bacteriol; 2023 Oct; 205(10):e0023823. PubMed ID: 37791754
[No Abstract] [Full Text] [Related]
9. A novel technique using potassium permanganate and reflectance confocal microscopy to image biofilm extracellular polymeric matrix reveals non-eDNA networks in Pseudomonas aeruginosa biofilms.
Swearingen MC; Mehta A; Mehta A; Nistico L; Hill PJ; Falzarano AR; Wozniak DJ; Hall-Stoodley L; Stoodley P
Pathog Dis; 2016 Feb; 74(1):ftv104. PubMed ID: 26536894
[TBL] [Abstract][Full Text] [Related]
10. Structure-Activity Relationships of Low Molecular Weight Alginate Oligosaccharide Therapy against
Pritchard MF; Powell LC; Adams JYM; Menzies G; Khan S; Tøndervik A; Sletta H; Aarstad O; Skjåk-Bræk G; McKenna S; Buurma NJ; Farnell DJJ; Rye PD; Hill KE; Thomas DW
Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759766
[TBL] [Abstract][Full Text] [Related]
11. Calcium-induced virulence factors associated with the extracellular matrix of mucoid Pseudomonas aeruginosa biofilms.
Sarkisova S; Patrauchan MA; Berglund D; Nivens DE; Franklin MJ
J Bacteriol; 2005 Jul; 187(13):4327-37. PubMed ID: 15968041
[TBL] [Abstract][Full Text] [Related]
12. A nanoscale characterization of the interaction of a novel alginate oligomer with the cell surface and motility of Pseudomonas aeruginosa.
Powell LC; Pritchard MF; Emanuel C; Onsøyen E; Rye PD; Wright CJ; Hill KE; Thomas DW
Am J Respir Cell Mol Biol; 2014 Mar; 50(3):483-92. PubMed ID: 24074505
[TBL] [Abstract][Full Text] [Related]
13. Overcoming drug resistance with alginate oligosaccharides able to potentiate the action of selected antibiotics.
Khan S; Tøndervik A; Sletta H; Klinkenberg G; Emanuel C; Onsøyen E; Myrvold R; Howe RA; Walsh TR; Hill KE; Thomas DW
Antimicrob Agents Chemother; 2012 Oct; 56(10):5134-41. PubMed ID: 22825116
[TBL] [Abstract][Full Text] [Related]
14. An in vitro study of alginate oligomer therapies on oral biofilms.
Roberts JL; Khan S; Emanuel C; Powell LC; Pritchard MF; Onsøyen E; Myrvold R; Thomas DW; Hill KE
J Dent; 2013 Oct; 41(10):892-9. PubMed ID: 23907083
[TBL] [Abstract][Full Text] [Related]
15. The role of alginate in Pseudomonas aeruginosa EPS adherence, viscoelastic properties and cell attachment.
Orgad O; Oren Y; Walker SL; Herzberg M
Biofouling; 2011 Aug; 27(7):787-98. PubMed ID: 21797737
[TBL] [Abstract][Full Text] [Related]
16. Alginate oligosaccharides enhance diffusion and activity of colistin in a mucin-rich environment.
Stokniene J; Varache M; Rye PD; Hill KE; Thomas DW; Ferguson EL
Sci Rep; 2022 Mar; 12(1):4986. PubMed ID: 35322119
[TBL] [Abstract][Full Text] [Related]
17. The roles of biofilm matrix polysaccharide Psl in mucoid Pseudomonas aeruginosa biofilms.
Ma L; Wang S; Wang D; Parsek MR; Wozniak DJ
FEMS Immunol Med Microbiol; 2012 Jul; 65(2):377-80. PubMed ID: 22309106
[TBL] [Abstract][Full Text] [Related]
18. The antimicrobial effects of the alginate oligomer OligoG CF-5/20 are independent of direct bacterial cell membrane disruption.
Pritchard MF; Powell LC; Khan S; Griffiths PC; Mansour OT; Schweins R; Beck K; Buurma NJ; Dempsey CE; Wright CJ; Rye PD; Hill KE; Thomas DW; Ferguson EL
Sci Rep; 2017 Mar; 7():44731. PubMed ID: 28361894
[TBL] [Abstract][Full Text] [Related]
19. Gum arabic capped-silver nanoparticles inhibit biofilm formation by multi-drug resistant strains of Pseudomonas aeruginosa.
Ansari MA; Khan HM; Khan AA; Cameotra SS; Saquib Q; Musarrat J
J Basic Microbiol; 2014 Jul; 54(7):688-99. PubMed ID: 24403133
[TBL] [Abstract][Full Text] [Related]
20. Incorporation of Farnesol Significantly Increases the Efficacy of Liposomal Ciprofloxacin against Pseudomonas aeruginosa Biofilms in Vitro.
Bandara HM; Herpin MJ; Kolacny D; Harb A; Romanovicz D; Smyth HD
Mol Pharm; 2016 Aug; 13(8):2760-70. PubMed ID: 27383205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]